MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma

BACKGROUND: Several studies suggest the role of circulating microRNAs (miRNAs) as biomarkers of hepatocellular carcinoma (HCC). However, the serum miRNA profile associated with the response to sorafenib remains to be elucidated. The aim of this study was to clarify the specific miRNAs in serum that...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Liver Cancer
Glavni autori: Nishida, Naoshi, Arizumi, Tadaaki, Hagiwara, Satoru, Ida, Hiroshi, Sakurai, Toshiharu, Kudo, Masatoshi
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2017
Teme:
Original Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5340220/
https://ncbi.nlm.nih.gov/pubmed/28275578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000449475
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items